Published in Br J Cancer on September 01, 2001
Medulloblastoma comprises four distinct molecular variants. J Clin Oncol (2010) 8.06
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One (2008) 5.86
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer (2010) 4.10
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol (2010) 2.04
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. J Clin Oncol (2011) 1.36
Childhood brain tumors: accomplishments and ongoing challenges. J Child Neurol (2008) 1.11
Molecular diagnostics in embryonal brain tumors. Brain Pathol (2011) 1.00
Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. BMC Cancer (2006) 0.97
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. Neuro Oncol (2012) 0.94
New chemotherapy strategies and biological agents in the treatment of childhood ependymoma. Childs Nerv Syst (2009) 0.88
Just say no to ATOH: how HIC1 methylation might predispose medulloblastoma to lineage addiction. Cancer Res (2008) 0.86
Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation. Neuro Oncol (2011) 0.86
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma. Childs Nerv Syst (2013) 0.85
Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement. Neuro Oncol (2012) 0.84
Recent advances in embryonal tumours of the central nervous system. Childs Nerv Syst (2005) 0.82
Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma. Neuro Oncol (2011) 0.82
Inhibition of epidermal growth factor signaling by the cardiac glycoside ouabain in medulloblastoma. Cancer Med (2014) 0.78
Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors. Acta Neuropathol Commun (2014) 0.78
Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies. Childs Nerv Syst (2006) 0.78
Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells. PLoS One (2014) 0.77
Gene expression of growth signaling pathways is up-regulated in CD133-positive medulloblastoma cells. Oncol Lett (2011) 0.77
Genetic grouping of medulloblastomas by representative markers in pathologic diagnosis. Transl Oncol (2013) 0.76
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma. Cell Rep (2017) 0.75
Appraisal of the current staging system for residual medulloblastoma by volumetric analysis. Childs Nerv Syst (2011) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol (1999) 11.78
The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J (2000) 9.51
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol (1999) 3.08
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys (2000) 2.33
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol (1999) 1.89
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol (2000) 1.44
C-MYC expression in medulloblastoma and its prognostic value. Int J Cancer (2000) 1.37
Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol (1995) 1.34
Long-term survivors of childhood cancer: the late effects of therapy. Oncologist (1999) 1.19
Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol (1995) 1.18
N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification. Tumori (1991) 1.16
Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol (1998) 1.08
Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation. Mol Pathol (2000) 0.99
Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma. Cancer Res (1998) 0.99
Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system. Clin Cancer Res (1997) 0.97
High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11.2. Genes Chromosomes Cancer (1997) 0.93
Correlation of chromosome 17p loss with clinical outcome in medulloblastoma. Clin Cancer Res (1996) 0.92
Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. Eur J Cancer (1997) 0.84
Potential prognostic value of C-erbB-2 expression in medulloblastomas in very young children. J Pediatr Hematol Oncol (1998) 0.79
Prognostic significance of molecular genetic markers in childhood brain tumors. Pediatr Neurosurg (1992) 0.79
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet (2000) 8.46
Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet (1998) 7.26
Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke (2001) 6.32
A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (2000) 6.12
Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet (1996) 5.95
Incorporation of surface tension into molecular dynamics simulation of an interface: a fluid phase lipid bilayer membrane. Biophys J (1995) 4.50
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2004) 3.69
Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol (1994) 3.46
The Internet and evidence-based decision-making: a needed synergy for efficient knowledge management in health care. CMAJ (2000) 3.46
Vitamin C exhibits pro-oxidant properties. Nature (1998) 3.22
Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci (1999) 3.16
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation (2000) 3.12
Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA (1996) 2.98
Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br (2005) 2.94
Gestational diabetes mellitus in India. J Assoc Physicians India (2004) 2.86
Evidence-based disease management. JAMA (1997) 2.85
Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol (1983) 2.60
Adverse impact of surgical site infections in English hospitals. J Hosp Infect (2005) 2.51
Renal impairment associated with non-steroidal anti-inflammatory drugs. Ann Rheum Dis (1987) 2.48
Pravastatin therapy and the risk of stroke. N Engl J Med (2000) 2.46
Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect (2003) 2.33
Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol (2001) 2.30
The joining of V and J gene segments creates antibody diversity. Nature (1980) 2.28
Do general practitioners' attitudes towards depression predict their clinical behaviour? Psychol Med (2000) 2.25
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci U S A (1996) 2.24
Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology (2006) 2.17
Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ (1992) 2.12
Hypoxic-reperfusion injury in the inflamed human joint. Lancet (1989) 2.11
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene (2010) 2.11
P53 overexpression in head and neck carcinoma and radiotherapy results. Int J Radiat Oncol Biol Phys (1996) 2.06
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
The SRCR superfamily: a family reminiscent of the Ig superfamily. Trends Biochem Sci (1994) 1.93
Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92
Sexually transmitted diseases in sexually abused children. Pediatrics (1983) 1.92
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
Does this patient have deep vein thrombosis? JAMA (1998) 1.90
Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol (1981) 1.86
Functional ambulation in patients with myelomeningocele. J Bone Joint Surg Am (1973) 1.85
The invasion of epithelial cell lines and the intestinal epithelium of infant mice by Campylobacter jejuni/coli. J Diarrhoeal Dis Res (1984) 1.84
Prevalence of gestational diabetes mellitus in South India (Tamil Nadu)--a community based study. J Assoc Physicians India (2008) 1.83
How expanding voluntary non-remunerated blood donations would benefit patients, donors and healthcare systems? Vox Sang (2011) 1.70
Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in-vivo demonstration of iron-promoted oxidant stress. Lancet (1987) 1.69
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat Med (1996) 1.68
Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). J Assoc Physicians India (2011) 1.68
The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology (1999) 1.68
Staff in Australian nursing homes: their qualifications, experience and attitudes. Contemp Nurse (1993) 1.67
STP position paper: best practice guideline for the routine pathology evaluation of the immune system. Toxicol Pathol (2005) 1.67
Tibio-femoral movement in the living knee. A study of weight bearing and non-weight bearing knee kinematics using 'interventional' MRI. J Biomech (2005) 1.66
Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem (1993) 1.65
EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. Gastrointest Endosc (2000) 1.64
Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess (Summ) (2005) 1.63
Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann Hum Genet (1994) 1.62
Structural transitions during bacteriophage HK97 head assembly. J Mol Biol (1995) 1.61
Runaway pacemaker rhythm after 36 hours of electrical inactivity. Br Heart J (1974) 1.60
Anoxygenic photosynthesis modulated Proterozoic oxygen and sustained Earth's middle age. Proc Natl Acad Sci U S A (2009) 1.58
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study. Lancet (2000) 1.56
Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill (2007) 1.55
Severe invasive Panton-Valentine Leucocidin positive Staphylococcus aureus infections in children in London, UK. J Infect (2009) 1.55
A single test procedure to diagnose gestational diabetes mellitus. Acta Diabetol (2008) 1.54
Cardiac effects of different tricyclic antidepressant drugs. Br J Psychiatry (1976) 1.54
Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology (2011) 1.53
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res (2001) 1.52
Drosophila scavenger receptor CI is a pattern recognition receptor for bacteria. Immunity (2001) 1.52
Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest (1985) 1.51
Surgical wound infection as a performance indicator: agreement of common definitions of wound infection in 4773 patients. BMJ (2004) 1.51
Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Neurosurgery (1998) 1.48
Postoperative radial artery angiography for coronary artery bypass surgery. Eur J Cardiothorac Surg (2000) 1.48
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer. Eur J Nucl Med (1993) 1.48
Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract (2010) 1.47
A method for generating hybrids containing nonselected fragments of human chromosomes. Genomics (1989) 1.47
p53 and p53-regulated genes in bladder cancer. Br J Urol (1998) 1.46
Is chronic synovitis an example of reperfusion injury? Ann Rheum Dis (1986) 1.45
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry (1999) 1.45
Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol (1997) 1.44
Simple technique for non-operative removal of ureteric stents after renal transplantation. Ann R Coll Surg Engl (1998) 1.42
Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis (1985) 1.41
Absence of cholinergic deficits in "pure" vascular dementia. Neurology (2005) 1.40
Injury prevention in primary care. Ann Intern Med (1990) 1.40
Gestational diabetes mellitus--Indian guidelines. J Indian Med Assoc (2009) 1.40
Electrical ablation of posteroseptal accessory pathways. Aust N Z J Med (1990) 1.40
Unilateral auditory hallucinations in a boy with ipsilateral conductive hearing loss. J Neurol Neurosurg Psychiatry (1997) 1.39
Catheter ablation of the atrioventricular node using radiofrequency energy. Aust N Z J Med (1994) 1.39
The investigation of chest pain: audit and intervention. Med J Aust (1993) 1.39
Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill (2008) 1.39
Resolution of intracardiac masses. J Thorac Cardiovasc Surg (1989) 1.38
Audit of specifically designed adenotonsillectomy operation sheet: how we do it. Clin Otolaryngol (2009) 1.38
Gestational diabetes mellitus--guidelines. J Assoc Physicians India (2006) 1.35
Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proc Natl Acad Sci U S A (2000) 1.35
Bundle-branch block in acute myocardial infarction. Br Med J (1969) 1.34
Permanent ventricular pacing via the great cardiac vein. Pacing Clin Electrophysiol (1994) 1.34
Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem (1999) 1.33
Sinus arrhythmia in acute myocardial infarction. Med J Aust (1978) 1.31
C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value. J Urol (1996) 1.30
Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT. Am J Physiol Renal Physiol (2001) 1.29
The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol (1975) 1.28